Dr. Sherva awarded NIH R01 Grant

Exploring mechanisms driving microbe-induced AD risk using next generations sequence data

Dr. Richard Sherva awarded NIH R01 grant

Multiple lines of evidence suggest microbial infections are risk factors for Alzheimer’s disease (AD). Amyloid-β (Aβ) peptides possess antimicrobial activity and may protect against human herpes viruses (HHV). Viral DNA is also detectable in Aβ plaques, and HHV DNA detected in next generation sequencing (NGS) experiments is associated with AD risk. Read More Here